Sort
16,300 grants matching “fatty liver disease”
Macrophage Dysfunction in Atherosclerosis and Cardiometabolic Diseases
$2,567,925Edward A Fisher · New York University School Of Medicine · P01 · FY2023 · HL
Macrophage Dysfunction in Atherosclerosis and Cardiometabolic Diseases
$2,567,925Edward A Fisher · New York University School Of Medicine · P01 · FY2022 · HL
Defining the mechanisms regulating adipose tissue metabolic memory and its role in rebound weight gain.
$2,559,138David Michael Merrick · University Of Pennsylvania · R01 · FY2025 · DK
A Cardiovascular-NASH disease nexus: Common Mechanisms and Treatments?
$2,537,053Christopher K Glass · University Of California, San Diego · P01 · FY2020 · HL
Aging as a Risk Factor and Target for Prevention of Liver Cancer
$2,531,382Peter D. Adams · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2021 · AG
Aging as a Risk Factor and Target for Prevention of Liver Cancer
$2,530,091Peter D. Adams · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2025 · AG
Preclinical drug development in pancreatic cancer
$2,528,211Udo Rudloff · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
A Cardiovascular-NASH disease nexus: Common Mechanisms and Treatments?
$2,525,060Christopher K Glass · University Of California, San Diego · P01 · FY2021 · HL
A Cardiovascular-NASH disease nexus: Common Mechanisms and Treatments?
$2,518,214Christopher K Glass · University Of California, San Diego · P01 · FY2022 · HL
Macrophage Dysfunction in Atherosclerosis and Cardiometabolic Diseases
$2,516,567Edward A Fisher · New York University School Of Medicine · P01 · FY2024 · HL
Nebraska Center for the Prevention of Obesity Diseases through Dietary Molecules
$2,516,001Janos Zempleni · University Of Nebraska Lincoln · P20 · FY2014 · GM
Discovery metabolite profiling of the prolyl peptidases
$2,514,500Alan Saghatelian · Harvard University · DP2 · FY2007 · OD
Mechanisms and biological consequences of the nuclear receptor CAR activation
$2,511,178Masahiko Negishi · National Institute Of Environmental Health Sciences · ZIA · FY2017 · ES
Identification of human genes of iron homeostasis
$2,510,131Caroline Philpott · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2021 · DK
Expression, Structure/function, Regulation, and Roles of PDE3 Isoforms
$2,499,647Vincent Manganiello · National Heart, Lung, And Blood Institute · ZIA · FY2012 · HL
Competing Renewal P01
$2,497,521Vishwa Deep Dixit · Yale University · P01 · FY2022 · AG
Identifying Diagnostic Markers for Cervical, Breast, and Prostate Cancer
$2,495,409Thomas Ried · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
A Cardiovascular-NASH disease nexus: Common Mechanisms and Treatments?
$2,492,476Christopher K Glass · University Of California, San Diego · P01 · FY2023 · HL
Southern Liver Health Cohort
$2,489,960Cathrine Hoyo · North Carolina State University Raleigh · UH3 · FY2023 · CA
Lipid Metabolism as a Determinant of Ferroptosis Sensitivity in Cancer
$2,489,032Xuejun Jiang · Sloan-Kettering Inst Can Research · P01 · FY2025 · CA
Biogenesis and Catabolism of Atherogenic Lipoproteins
$2,485,299M Mahmood Hussain · Nyu Long Island School Of Medicine · P01 · FY2023 · HL
New Approaches to Reduce Residual Cardiovascular Risk
$2,484,600Jay D Horton · Ut Southwestern Medical Center · P01 · FY2023 · HL
New Approaches to Reduce Residual Cardiovascular Risk
$2,484,600Jay D Horton · Ut Southwestern Medical Center · P01 · FY2022 · HL
New Approaches to Reduce Residual Cardiovascular Risk
$2,484,600Jay D Horton · Ut Southwestern Medical Center · P01 · FY2025 · HL
General Clinical Research Center
$2,478,297Sheldon M Retchin · Virginia Commonwealth University · M01 · FY2007 · RR